{(2S,3S,5R)-5-[4-amino-3-(trifluoromethyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-3-hydroxytetrahydrofuran-2-yl} methyl sulfamate

ID: ALA4532458

Chembl Id: CHEMBL4532458

PubChem CID: 134500689

Max Phase: Preclinical

Molecular Formula: C11H13F3N6O5S

Molecular Weight: 398.32

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Nc1ncnc2c1c(C(F)(F)F)nn2[C@H]1C[C@H](O)[C@H](COS(N)(=O)=O)O1

Standard InChI:  InChI=1S/C11H13F3N6O5S/c12-11(13,14)8-7-9(15)17-3-18-10(7)20(19-8)6-1-4(21)5(25-6)2-24-26(16,22)23/h3-6,21H,1-2H2,(H2,15,17,18)(H2,16,22,23)/t4-,5-,6+/m0/s1

Standard InChI Key:  YJFDMVOGTJSYBI-HCWXCVPCSA-N

Alternative Forms

  1. Parent:

    ALA4532458

    ---

Associated Targets(Human)

ATG7 Tchem Ubiquitin-like modifier-activating enzyme ATG7 (562 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 398.32Molecular Weight (Monoisotopic): 398.0620AlogP: -0.70#Rotatable Bonds: 4
Polar Surface Area: 168.47Molecular Species: NEUTRALHBA: 10HBD: 3
#RO5 Violations: 0HBA (Lipinski): 11HBD (Lipinski): 5#RO5 Violations (Lipinski): 1
CX Acidic pKa: 11.33CX Basic pKa: 3.27CX LogP: -0.51CX LogD: -0.51
Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.60Np Likeness Score: -0.23

References

1.  (2018)  Atg7 inhibitors and the uses thereof, 

Source